Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Knowing when to choose cash back over points on credit cards can save you money. Learn the scenarios that favor cash back!
27,373 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A surprise leadership shift at JPMorgan ends years of grooming female executives for the corner office. Marianne Lake...
Thinking about should tesla stock before July 22 earnings? This guide breaks down potential catalysts, risk factors, ...
After a long hiatus from the tech scene, Peter Steinberger—a millennial coder turned OpenClaw founder—re-emerged to w...
Investors are eyeing a smarter play bitcoin recovery that avoids direct bitcoin ownership while still tapping into th...
Solana looks poised at a crossroads as derivatives data shows a long-dominant tilt without fresh capital. The solana ...
Bitcoin faced a sharp test as ETF-related outflows spiked, pushing BTC toward important support levels. Traders are w...
A trio of ETFs focusing on nuclear and uranium stocks is catching investor attention as AI computing expands. The cas...
A June breach hit Humanity Protocol’s H token on Ethereum and BNB Smart Chain, revealing key-management vulnerabiliti...
A major Ethereum Layer-2 network, Taiko, halted block production after an exploit. Blockaid suggests the root cause l...
XRP closed June with a 22% plunge, yet history suggests July could bring a pronounced rebound as ETF inflows persist ...
A new model from Google Gemini AI projects a bold Solana price target for 2026, highlighting infrastructure upgrades ...